ADVISORY, March 5, 2015 (GLOBE NEWSWIRE) -- What: Summit Therapeutics PLC (Nasdaq:SMMT), the drug discovery and development company advancing therapies for Duchenne Muscular Dystrophy and C ...

Especially high volume was seen for the $25 strike call option expiring July 18, 2025, with 1,411 contracts trading so far today, representing approximately 141,100 underlying shares of SMMT.

In recent trading, shares of Summit Therapeutics Inc (Symbol: SMMT) have crossed above the average analyst 12-month target price of $35.57, changing hands for $36.70/share. When a stock reaches ...

The week kicked off in style for Summit Therapeutics (NASDAQ:SMMT) with the shares soaring by 56% in Monday’s trading session. To be fair, while those are certainly nice gains, it’s not as if ...

Summit Therapeutics PLC (SMMT) closed the last trading session at $25.85, gaining 10.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...

Shares of lung cancer-focused biotech Summit Therapeutics (NASDAQ: SMMT) rallied 16.6% at its highs of the day before settling into a 10.4% gain on Thursday as of 3:54 p.m. EDT, even though the ...

Below is Validea's guru fundamental report for SUMMIT THERAPEUTICS INC (SMMT). Of the 22 guru strategies we follow, SMMT rates highest using our Small-Cap Growth Investor model based on the ...

Fintel reports that on March 21, 2025, Cantor Fitzgerald initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Overweight recommendation. As of March 18, 2025, the average one-year ...

Summit Therapeutics plc ( SMMT ) is a biopharmaceutical company that could be an interesting play for investors. That is because, not only does the.

Summit Therapeutics PLC (SMMT) closed the most recent trading day at $3.75, moving +1.08% from the previous trading session. This change outpaced the S&P 500's 0.82% gain on the day. At the same ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Summit Therapeutics (SMMT) one of those stocks right now?